Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Expects to Initiate Phase 2 Study in 2H 2026, Study Plans to Enroll 6-8 Pediatric and Adult Patients in the U.S. and EuropeFDA Expressed No Safety Concerns Over Study Design and Duration of Dosi ...

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Expects to Initiate Phase 2 Study in 2H 2026, Study Plans to Enroll 6-8 Pediatric and Adult Patients in the U.S. and EuropeFDA Expressed No ...

Quoin Advances QYLEKI Toward First Netherton Therapy

Detailed price information for Quoin Pharmaceuticals Ltd ADR (QNRX-Q) from The Globe and Mail including charting and trades.
The Manila Times

Quoin Pharmaceuticals Receives FDA Conditional Approval of QYLEKI™ as the Proposed Brand Name for QRX003 for Netherton Syndrome

QRX003 Holds Orphan Drug Designation in the United States, the European Union, and Japan, Plus Fast Track and Rare Pediatric Disease Designations from the FDAPivotal Phase 3 Study Expected to Initiate ...
Women's Health

The 5 Best Walking Shoes for Plantar Fasciitis, Tested and Reviewed by a Fitness Editor

DEALING WITH PLANTAR fasciitis is a huge bummer. The condition, which causes pain and inflammation in the thick band of tissue that runs along the bottom of your foot, can make your morning walk or ...
The Globe and Mail

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

ASHBURN, Va., June 04, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) ("Quoin" or the "Company"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...
CMAJ

Genetic palmoplantar keratoderma associated with SERPINA12 mutations

A 3-year-old girl presented to our dermatology clinic with a 2-year history of pruritic, symmetric skin thickening and erythema involving the palms and soles, extending to the dorsal surfaces (Figure ...
Monthly Prescribing Reference

Sonelokimab Receives FDA Fast Track Status for Palmoplantar Pustulosis

Data from the phase 2 LEDA trial demonstrated that sonelokimab treatment led to meaningful improvements in patients with PPP. The Food and Drug Administration (FDA) has granted Fast Track designation ...
Medical Xpress

Researchers establish the cause of keratoderma-associated foot odor

The distinct foot odor that comes with the skin disorder Nagashima-type palmoplantar keratosis (NPPK) is caused by the overgrowth of a specific bacterial strain, according to a study published in the ...
EurekAlert!

Sniffing out the cause of keratoderma-associated foot odor

The distinct foot odor that comes with the skin disorder Nagashima-type palmoplantar keratosis (NPPK) is caused by the overgrowth of a specific bacterial strain. The Kobe University result also shows ...
The Hitavada

WINDOW ON VIDARBHA After hair lossand nail loss...Now, cracks in handsreported in Buldhana

AFTER cases of hair loss and later nail loss were reported in the district, now, sudden increase in complaints of cracks on palms have come to fore in Shelgaon Deshmukh, a village in Mehkar taluka.